UroGen Pharma Ltd. (URGN) stock
URGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$27.65−4.08 (-12.86%)
Close on Nov 20, 2026Market cap $1.35BP/E –Yield –
UroGen Pharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
UroGen Pharma's price to book ratio was 18.2× on Jan 31, 2025, against 6.8× a year earlier. Over the last 5 years it ranged from 2.1× to 23.3×, with a median of 5.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jan 31, 2025 | 18.2× | +0.6 |
| 2024 | Dec 31, 2024 | 17.6× | −1.2 |
| 2022 | Apr 29, 2022 | 18.9× | +12.1 |
| 2021 | Dec 31, 2021 | 6.8× | +3.5 |
| 2020 | Dec 31, 2020 | 3.3× | −0.0 |
| 2019 | Dec 31, 2019 | 3.3× | −3.4 |
| 2018 | Dec 31, 2018 | 6.7× | +1.4 |
| 2017 | Dec 29, 2017 | 5.3× | – |
See a number that looks wrong?